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ABSTRACT
Introduction While nearly half of all new psychotic 
disorders are diagnosed in the emergency department 
(ED), most young people who present to the ED with 
psychosis do not receive timely follow- up with a 
psychiatrist, and even fewer with evidence- based early 
psychosis intervention (EPI) services. We aim to test an 
intervention delivered using short message service (SMS), 
a low- cost, low- complexity, youth- friendly approach, to 
improve transitions from the ED to EPI services.
Methods and analysis This is a protocol for a pragmatic 
randomised, single blind, controlled trial with accompanying 
economic and qualitative evaluations conducted at the 
Centre for Addiction and Mental Health (CAMH) in Toronto, 
Canada. A consecutive series of 186 participants aged 
16–29 referred by the ED to CAMH’s EPI programme will 
be recruited for a trial of a two- way intervention involving 
reminders, psychoeducation and check- ins delivered via 
SMS. The primary outcome will be attendance at the first 
consultation appointment within 30 days of study enrolment 
assessed through chart reviews in the electronic health 
record. We will also extract routine clinical measures, 
including the Brief Psychiatric Rating Scale, Clinical 
Global Impression and Service Engagement Scale, and 
link with provincial health administrative data to examine 
system- level outcomes, including ED visits and psychiatric 
hospitalisations, 6 months and up to 2 years after baseline. 
We will perform a cost- effectiveness analysis of the 
primary study outcome and costs incurred, calculating an 
incremental cost effectiveness ratio. Web- based surveys 
and qualitative interviews will explore intervention user 
experience. Patients and families with lived experience will 
be engaged in all aspects of the project.
Ethics and dissemination Research Ethics Board 
approval has been obtained. Findings will be reported in 
scientific journal articles and shared with key stakeholders 
including youth, family members, knowledge users and 
decision makers.
Trial registration number NCT04298450.
INTRODUCTION
Psychosis, characterised by delusions and/
or hallucinations, typically manifests during 
adolescence or early adulthood. It is the char-
acteristic presentation of schizophrenia and 
schizoaffective disorder, and often occurs in 
bipolar disorder.1 These disorders can cause 
significant dysfunction: in disability weighting 
surveys used to establish global disease 
burden, participants rated schizophrenia as 
Strengths and limitations of this study
 ► Pragmatic randomised controlled trial leveraging 
mobile health technology, chart reviews, routinely 
collected administrative data, and economic and 
qualitative evaluations.
 ► Intervention well- positioned for local adoption as 
well as scale and spread to other early psychosis 
intervention programmes and youth mental health 
services more broadly.
 ► Collaboration with health system decision- makers, 
clinical stakeholders, knowledge users, team mem-
bers with clinical and research expertise, people 
with lived experience of psychosis, and key relation-
ships with organisations well- positioned to support 
widespread implementation.
 ► Conducting the trial at a single site will support 
streamlined recruitment but may limit generalisabil-
ity of our findings.
 ► The pragmatic data collection methods being used, 
particularly chart review, may be subject to unreli-
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the disorder most disabling for individuals.2 Young people 
experience greater mortality by up to 24- fold in the year 
following a first psychotic disorder diagnosis compared 
with peers in the general population.3 In the long term, 
psychotic disorders are associated with ongoing increased 
mortality particularly by suicide,4 substance use disor-
ders, homelessness, victimisation, acts of violence5 and 
high economic costs due to healthcare use as well as lost 
productivity.6 7 Early psychosis intervention (EPI) is a 
model developed to provide treatment early in the course 
of illness to improve patients’ long- term trajectories and 
reduce the burden on individuals and their families. 
The rationale for EPI has been strengthened by consis-
tent findings that long duration of untreated psychosis 
is associated with greater symptom burden, lower likeli-
hood of remission and poor social functioning and global 
outcomes.8 Members of our team have shown that EPI 
service use is associated with a fourfold reduction in all- 
cause mortality for young people with psychosis compared 
with those who do not access EPI services.9 EPI services 
have also been associated with improved access to psychi-
atric care, reduced risk of relapse, fewer hospital readmis-
sions and increased employment rates.9–13 EPI can be a 
lifechanging and lifesaving intervention for young people 
with psychosis.
EPI programmes are well- established in Ontario and 
provide services to young people with early psychosis 
across the province.14 Despite this, and the clear mandate 
for EPI programmes to promote their services and 
minimise barriers to care, many youth with psychosis 
in Ontario either never access these services, or enter 
them far later than indicated.15 In Canada, nearly half of 
all new psychotic disorders are diagnosed in the emer-
gency department (ED).16 We recently found that among 
young people across Ontario presenting with psychotic 
disorders to the ED for the first time, 40% received no 
outpatient mental health follow- up within 30 days and 
only 45% saw a psychiatrist.17 The reasons young people 
with psychosis discharged from the ED did not receive 
follow- up were unclear in this study: both issues of access 
(availability and awareness of services) and engagement 
(youth following through on referrals) are potential 
explanations. Our experience at the Centre for Addic-
tion and Mental Health (CAMH) in Toronto, where our 
EPI programme sees referred patients for consultation 
within 2 weeks on average, suggests a problem of engage-
ment: according to clinic data, 50% of the youth referred 
from the ED do not attend their first EPI consultation 
appointment (compared with approximately 30% from 
all other referral sources). It is clear that new approaches 
are required to engage this population in accessing 
evidence- based care that is life- saving and improves illness 
outcomes. In surveys of patients and families in EPI 
services, appointment reminders are cited as a top factor 
that would improve service engagement, with a prefer-
ence for email and text communication.18–20
Mobile health technologies are increasingly being 
tested to improve outcomes, including symptoms, 
appointment attendance and medication adherence, 
among young people with mental illness, particularly 
psychosis.21–23 Short message service (SMS) or text 
message is a commonly used mode of communication 
by adolescents and young adults: in a survey of users 
of community mental health services, access to mobile 
phones approached 100%.24 SMS is associated with low 
user and financial burden. SMS does not require people 
to own a smartphone, have data plans, or have access 
to wireless internet. In a study of people with psychosis, 
participants were found to be highly engaged with an 
SMS intervention.25 SMS reminders have been associated 
with improved service engagement in psychosis across 
studies,22 including twice the attendance rates for initial 
appointments in an EPI programme.26 An ongoing pilot 
study at CAMH investigating the effect of a weekly two- 
way SMS intervention on service engagement during 
the first year of EPI treatment found this approach to 
be feasible and valued by participants.27 We are unaware 
of any studies examining interventions specifically to 
improve the transition in care from the ED to EPI for 
young people with psychosis, using mobile health tech-
nologies or otherwise.
Objectives and hypotheses
‘ED to EPI’, a pragmatic randomised, single blind, 
controlled trial28 with accompanying economic and qual-
itative evaluations, aims to improve the transition from 
the ED to EPI services for youth with psychosis using 
an SMS text messaging intervention. It is pragmatic in 
its participant eligibility criteria (broad and inclusive), 
comparison intervention (usual care), follow- up intensity 
(low), primary trial outcome (objective, meaningful and 
assessed under usual conditions), measurement of partic-
ipant compliance and practitioner adherence to study 
protocol (unobtrusive) and analysis of primary outcome 
(inclusive, ie, intention- to- treat).29 We also leverage 
linked routinely collected data through ICES (previously 
known as the Institute for Clinical Evaluative Sciences), 
which holds data on all hospital and physician visits for 
the province. We will also evaluate the cost effectiveness of 
the intervention and explore young people’s perspectives 
on its various components. Our study team, in addition to 
clinicians and researchers, includes a patient and family 
member with lived experience of using EPI services and 
key decision- makers to increase the relevance and uptake 
of the intervention. Specifically, our primary objectives 
are to:
1. Evaluate the effect of an SMS intervention on atten-
dance at the first consultation appointment within 30 
days of study enrolment.
Hypothesis 1: The SMS intervention will increase rate 
of attendance at the consultation appointment.
2. Assess indicators of longer- term service engagement 6 
months following study enrolment.
Hypothesis 2: The SMS intervention will lead to 
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(Service Engagement Scale (SES) scores and dropout 
rates).
3. Determine system- level outcomes, including ED visits 
and psychiatric hospitalisations, as a function of receiv-
ing the SMS intervention, and its cost effectiveness, 
factoring costs of the intervention and cost offsets of 
health service utilisation.
Hypothesis 3: The SMS intervention will lead to 
decreased use of acute care services (ED visits and 
psychiatric hospitalisations) and will be cost- effective 
relative to the control condition, based on improved 
rate of transition from the ED to EPI services and antic-
ipated reductions in use of costly acute care services.
4. Explore young people’s experiences of the interven-
tion and their perspectives on its various components.
This is an exploratory research question that seeks to 
understand how young people experience the SMS inter-
vention and how they perceive its various components 
impact their service engagement.
METHODS AND ANALYSIS
Study setting
The study setting will be the Gerald Sheff and Shanitha 
Kachan Emergency Department at CAMH, Ontario’s only 
24 hours stand- alone psychiatric emergency service. The 
ED also houses a drop- in ‘Bridging Clinic’ which provides 
care to less acute patients who are diverted after ED 
triage, and rapid follow- up care for patients discharged 
from the ED and CAMH inpatient units. Together, they 
serve approximately 1200 patients each month. The 
EPI programme at CAMH receives over 600 referrals 
for suspected psychosis annually, approximately 25% of 
which are from the ED and Bridging Clinic. Reflecting 
the Ontario EPI Programme Standards, CAMH EPI 
services are delivered by multidisciplinary teams, employ 
strategies to promote early entry and ongoing engage-
ment, and provide pharmacotherapy and psychosocial 
therapies for an average of 3 years.14 Patients are assigned 
to the next available and/or most appropriate psychiatrist 
and case manager (nurse, social worker or occupational 
therapist) for a joint consultation appointment, typically 
within 2 weeks, and are contacted by phone by the EPI 
programme administrator to book and confirm their 
appointment. After the initial appointment is confirmed, 
patients receive a phone call reminder the day before 
their scheduled appointment. As part of routine care, 
patients who do not attend their scheduled first appoint-
ment receive follow- up calls to reschedule an appoint-
ment for up to 30 days from the initial referral.
Eligibility criteria
Study inclusion criteria mirror the intake criteria for the 
CAMH EPI programme. Participants will be eligible for 
the study if they: (i) are between 16 and 29 years old and 
(ii) have been referred by the CAMH ED to CAMH EPI 
services for suspected psychosis. Our only exclusion crite-
rion is inability to communicate in basic written English. 
In our pilot SMS study at CAMH, fewer than 5% of poten-
tial participants were excluded for lacking a phone; we 
have budgeted to offer 5% of participants access to a 
prepaid cellphone for the duration of the study.27
Intervention procedures
Study participants will be recruited at the time of EPI 
referral for a trial of an SMS intervention designed to 
engage them during the waiting period for their consul-
tation appointment. They will be randomised to receive 
either sham or active SMS intervention.
Sham SMS will consist of one message sent just after 
enrolment indicating that they will be contacted for an 
appointment. The sham SMS group will not be denied any 
part of usual clinical care. Thus, the clinic administrator 
will call patients in both groups to book and remind them 
of the consultation appointment. Active SMS intervention 
will include the initial message sent to the control group, 
plus a series of subsequent messages. These will include 
the following content: (i) appointment reminders and 
instructions, (ii) psychoeducational material and (iii) two- 
way communication check- ins to rate distress (figure 1). 
Intervention components were developed based on feed-
back from a survey of youth in the same EPI programme,30 
as well as psychosocial interventions with evidence in 
early psychosis, including cognitive- behavioural therapy 
(psychoeducation, behavioural activation) and illness 
self- management (reminders, distress check- in).31 32 See 
online supplemental file 1 for a comprehensive descrip-
tion of the intervention. Messages sent back by partici-
pants will be monitored by the research team, and the 
case manager assigned to their consultation appointment 
will be notified and will respond accordingly if there 
are indicators of elevated distress. The intervention will 
continue until the patient attends the first consultation 
appointment, or for up to 30 days if the patient does not 
attend, which reflects the programme’s practice of closing 
referrals for non- attending patients.
Messages will be sent through CAMH’s in- house 
Research Electronic Data Capture (REDCap) platform 
via a third- party plug- in, Twilio, which supports routing 
of SMS messages to participant devices.33–35All data 
are stored securely on CAMH’s REDCap servers or in 
a locked office and password- protected database on 
CAMH’s secure network. The purpose of the sham inter-
vention is to separate out the content of the intervention 
(ie, reminders, psychoeducation, two- way check- ins) from 
the effect of simply receiving SMS messages, decreasing 
participant bias.
Assignment of intervention
Immediately after informed consent, participants will be 
randomised by REDCap to the active or sham interven-
tion. Generation of the randomisation sequence will be 
managed by the study biostatistician who is not involved 
in enrolling participants or assigning intervention arms. 
Randomisation will be stratified by sex (male or female) 
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computer algorithm to determine a randomised, blocked 
allocation of participants into intervention groups within 
strata. Once randomised, treatment assignment will be 
known only by the study personnel involved in managing 
the SMS intervention and the case manager monitoring 
text message responses; the principal investigator and 
study personnel involved in the chart review and the ICES 
analysis will remain blind to treatment assignment. Study 
personnel involved in the qualitative interviews and anal-
ysis will also be aware of treatment assignment since only 
individuals receiving the active intervention will partici-
pate in this component of the project.
Sample size
Our sample size calculations are based on the primary 
outcome of rate of attendance at the EPI programme 
consultation appointment. The current rate of atten-
dance at the first consultation appointment for patients 
referred from the ED and Bridging Clinic is 50%; we have 
powered our study to detect the treatment effect with 
an anticipated rate of attendance of 70%, which is the 
average for all referral sources other than the ED and 
Bridging Clinic. A total of 186 participants (93 per group) 
will provide >80% power to detect a change in atten-
dance from 50% to 70% at alpha <0.05. Non- compliance 
and loss to follow- up are not a concern for our primary 
outcome since these are counted in the outcome as non- 
attendance at the consultation. Adjusting analyses for 
covariates expected to affect attendance (eg, age, sex) is 
expected to further increase power.
Study procedures
We will recruit 186 patients consecutively referred from 
the CAMH ED and Bridging Clinic to the CAMH EPI 
programme at the time of discharge. During business 
hours and into the evening, research staff will be on call 
to the ED to recruit patients as soon as they are identi-
fied for the study. Eligible participants who present after 
hours may be identified by ED staff and referred to the 
research team who will send them an e- consent form via 
SMS or email. See online supplemental file 2 for patient 
consent form. Additionally, potential participants who 
are missed in the ED/Bridging Clinic may be identified 
by the EPI clinic administrator who will approach them 
Figure 1 Study intervention schedule. This figure represents a summary of the intervention schedule and is not exhaustive of 
text message content. Left arrow, outgoing text messages sent by participants; right arrow, incoming text messages received 
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over the phone and send them an e- consent form via SMS 
or email. We have used the approach of having clinical 
and administrative staff obtain verbal consent to send 
e- consent forms in other studies with this population.19
As part of informed consent, participants will be asked 
to consent to a review of their chart, a follow- up web- 
based survey, and linkage of their information to data 
held at ICES. They will also be given the option to provide 
consent to be re- contacted for participation in a qual-
itative interview. There will be no additional in- person 
assessments for the quantitative component of this study. 
CAMH uses an electronic health record, which facilitates 
data abstraction from multiple clinical programmes (ie, 
both the ED and Bridging Clinic and EPI programme). 
Research staff and students will be trained by the clinician 
principal investigators to abstract data into a structured 
database.
All study participants will receive a $10 e- giftcard once 
the baseline e- visit is complete. Participants in the active 
intervention group who complete a web- based survey will 
receive another $10 e- giftcard and those who complete a 
qualitative interview will receive a $50 e- giftcard. It will be 
clarified through the consent process that honoraria are 
to compensate participants for their time and will not be 
tied to clinical appointment attendance. For the majority 
of participants, their initial recruitment and consent will 
be their only interaction with the research team, with a 
small subgroup completing qualitative interviews.
Outcome measures
Chart review
Outcome measures are shown in table 1. CAMH uses 
many standardised assessment forms which increases the 
completeness of patient data. Demographic variables, 
clinical diagnoses, substance use, duration of untreated 
psychosis (measured as the period of time from first onset 
of psychotic symptoms to initiation of EPI services and 
initiation of treatment with an antipsychotic or mood- 
stabilising medication), characteristics of the ED visit 
from which they were referred (urgent presentation—
brought by police, involuntary status; timing of visit), and 
family involvement in care are routinely recorded in the 
clinical chart by clinicians and will be abstracted from 
the chart at the time of consultation. Additional vari-
ables will likely be available but only for patients accepted 
into the EPI programme, and this will be reflected in the 
data analysis. These include several assessments that are 
performed routinely in the EPI programme. The SES36 is 
a brief validated tool designed to measure engagement 
with community mental health services. In 14 items, it 
assesses patients’ availability for treatment, collabora-
tion, help- seeking behaviours and treatment adherence 
on a four- point Likert scale with higher scores indicating 
difficulties in service engagement. The Brief Psychiatric 
Rating Scale37 is a clinician or interviewer- rated measure 
of psychiatric symptoms commonly used as an outcome 
measure for psychotic disorders and collected monthly 
in CAMH’s EPI programme. It includes items related 
to suicidality and hostility. The Clinical Global Impres-
sion38 is a clinician- rated measure of the patient’s global 
severity of illness prior to and after initiating a medica-
tion. It includes subscales for severity and improvement. 
Medication and appointment non- adherence will also 
be assessed over 6 months of treatment. Finally, after 6 
months, current EPI enrolment status will be assessed and 
categorised as: not offered or enrolled in treatment (eg, 
because they did not ultimately have psychosis), enrolled 
but disengaged prematurely, accepted for treatment 
but transitioned to other services or continued in treat-
ment. Data abstractors will undergo rigourous training 
and monitoring, use standardised extraction forms, and 
calculate inter- rater reliability.
Administrative data
Primary data collected for the study will be linked deter-
ministically to data sources held at ICES via participants’ 
unique health card numbers. The information available 
for each participant will be de- identified, stored and anal-
ysed onsite at ICES following procedures approved by 
Ontario’s Information and Privacy Commissioner. The 
following ICES data sources will be used: the Ontario 
Mental Health Reporting System, capturing hospitalisa-
tions on adult inpatient mental health units,39 the Cana-
dian Institute of Health Information Discharge Abstract 
Database, capturing all hospital admissions including 
hospitalisations on child and adolescent inpatient mental 
health units,40 41 National Ambulatory Care Reporting 
System which captures all ED visits,42 Ontario Health 
Insurance Plan claims database, which captures outpa-
tient physician visits,40 Registered Persons Database, 
which contains health card numbers, demographic infor-
mation, and deaths, and Ontario Drug Benefits claims 
database, which provides information on all covered 
prescriptions (based on financial need for those under 
age 65 and for young people up to age 25 who lack private 
insurance). These data will also be used for cost effective-
ness analysis. Outcomes examined in the linked ICES 
data are listed in table 1.
Statistical analysis
Primary analysis
Descriptive and graphical statistics will be used to 
summarise the data on all randomised participants and 
to confirm that there are no group differences in baseline 
demographics and clinical characteristics. Distributional 
assumptions will be inspected and appropriate transfor-
mations or non- parametric methods will be applied as 
necessary. In general, generalised linear models43 will be 
used throughout. These models account for deviation 
from normal assumption of the outcome variables and 
control for covariates.
Our analysis of the primary outcome will be a logistic 
regression to examine the likelihood of attendance at the 
EPI consultation with treatment assignment using risk 
ratios.44 We will carefully select demographic variables 
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Table 1 Summary of outcome measures and covariates
Type Variables Data source Timing
Demographic 
characteristics
Age Chart review for 
all demographic 
characteristics (CAMH 
Health Equity form 
and notes)
Baseline*
  Sex and gender
  Sexual orientation
  Race/ethnicity
  Born in Canada
  Religious/spiritual affiliation
  Highest level of education
  Source of income and family income
  Number of people supported by income
  Employment status
  Legal history
  Housing status
  Living situation
  Experience of homelessness
  Relationship status
Clinical 
characteristics





  Substance use Baseline
  DUP Baseline
  Family involvement in care Baseline
  Urgent status at ED visit (brought by police, 
involuntary)
  Timing of ED visit   
  BPRS37   Baseline and 6 months
  CGI38   Baseline and 6 months




  SES36 6 months (completed around 3 
months in treatment)
  Medication and appointment non- adherence 6 months
  EPI enrolment status 6 months
System- level 
outcomes†
Number of ED visits NACRS42 6 months and up to 2 years








  Number of outpatient mental health visits OHIP40
  Prescription drugs—psychiatric medications, 
continuously vs non- continuously prescribed
ODB
  Mortality including cause of death Registered Persons 
Database
*Items may be extracted from the ED note or EPI consultation note.
†Administrative data held at Institute for Clinical Evaluative Sciences.
BPRS, Brief Psychiatric Rating Scale; CAMH, Centre for Addiction and Mental Health; CGI, Clinical Global Impression; CIHI- DAD, Canadian 
Institute of Health Information Discharge Abstract Database; DUP, duration of untreated psychosis; ED, emergency department; EPI, early 
psychosis intervention; NACRS, National Ambulatory Care Reporting System; ODB, Ontario Drug Benefits; OHIP, Ontario Health Insurance 
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(eg, substance use, family involvement in care)45 to 
be included in the model as covariates. A difference in 
attendance between groups will be declared at a signifi-
cance level of 0.05. Similar models will be used to address 
the secondary hypotheses, with specific types of models 
appropriate to each outcome, including time- to- event 
analysis to examine premature disengagement from 
services. Administrative data outcomes will be examined 
using generalised linear models with proper distribution 
assumptions.
Additional analyses: moderation and generalisability
We plan to conduct two additional exploratory anal-
yses. First, we will run moderation analyses on potential 
effect modifiers by adding an interaction term between 
the potential moderator and the treatment assignment 
indicator in the generalised linear models. We are specifi-
cally interested in the moderation effects of health equity 
factors including gender, race/ethnicity and housing 
status. A significant interaction will provide evidence that 
the treatment effects may be different in the subgroups. 
A second exploratory analysis will be conducted to eval-
uate the impact of selection bias of the study sample and 
estimate the population average treatment effects by 
employing weighted analysis using propensity scores.46
Missing data
The risk of missing data is mitigated through the use of 
chart review and analysis of administrative data. While 
the primary outcome will not suffer from attrition, other 
outcomes will, as some follow- up data will only be avail-
able for participants who attended their consultation 
appointment and those who are enrolled in CAMH EPI 
services. For these additional outcomes, we plan to use 
multiple imputation methods developed by Schafer to 
correct potential bias that could be introduced by missing 
data.47
Economic evaluation
Full details of the economic evaluation appear in 
online supplemental file 3. We will undertake a cost- 
effectiveness analysis, where the outcome of interest 
is consultation appointment attendance, adopting 
the perspective of the public third- party payer (ie, the 
Ontario Ministry of Health). We will collect data on the 
costs of delivering both arms of the intervention. In 
addition, using a costing algorithm available at ICES,48 
we will estimate all direct patient- level healthcare costs 
incurred by the public third- party payer for the inter-
vention and control groups, which will include costs of 
hospitalisations, ED visits, physician services (ie, primary 
care, psychiatry and other) and diagnostic tests, outpa-
tient prescription drugs for individuals covered under 
the provincial public drug insurance plan, and other 
hospital- based care. We will calculate the incremental 
cost- effectiveness ratio as the difference in discounted 
mean costs between the intervention and control 
groups, divided by the difference in attendance rates. 
We will use a net benefit regression approach to model 
probabilities of cost effectiveness for each additional 
patient referred who attends their consultation appoint-
ment in the intervention compared with control group. 
In addition, we will undertake relevant sensitivity anal-
yses to test the robustness of findings by varying relevant 
parameters, such as the discount rate. Finally, we will 
examine the real- world budget impact of implementing 
the intervention across Ontario, to estimate the cost to 
the Ministry of Health of implementing this model of 
care across the province and the potential cost- savings 
to the system associated with this.
Understanding patient experiences: survey and qualitative analysis
Participants in the active intervention group will receive 
a one- time survey sent as a web- link to their phone or 
email address. Survey topics include user experience, 
attitudes toward the SMS intervention, its perceived 
benefits and challenges, acceptability and suggestions 
for improvements. Those who consent to participate in 
the qualitative research component will be recontacted 
by phone or email to participate in semi- structured inter-
views to gain a more in- depth understanding of survey 
topics. A subsample of 10–15 participants in the active 
intervention group will be purposively selected to maxi-
mise diversity of age, gender and service attendance. We 
will use critical realist theory as an underlying frame-
work to guide our interviews, surveys and analysis.49 
Interviews will be completed until thematic saturation 
is achieved, estimated at 12 participants. Interviews will 
be digitally audio- recorded and transcribed verbatim. 
Surveys will be completed and stored in REDCap. Tran-
scriptions and survey responses will be analysed using 
thematic content analysis in NVivo-11. Research partic-
ipants will be invited to assist with member checking to 
confirm that themes reflect their experiences. The anal-
ysis can inform future improvements to the intervention 
and considerations for broader implementation, privi-
leging the experiences of the patients attending these 
programmes.
Patient and public involvement
A youth and family member who previously received EPI 
services have been engaged in helping shape the inter-
vention and study design from project inception. They 
are active members of the project’s Steering Committee 
that meets monthly to inform study design, implementa-
tion, evaluation, and dissemination of results. They will 
have key roles in the plan to spread the intervention, if 
successful, to other EPI programmes by working with 
patients and families to adapt the intervention to local 
contexts. Additional youth with lived experience of 
receiving EPI services have been consulted on an ad hoc 
basis through the CAMH Youth Engagement Initiative 
to provide detailed feedback on the SMS intervention. 
Patient and family representatives on the research team 
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ETHICS AND DISSEMINATION
The study was approved by the Research Ethics Board 
(REB) at the CAMH. The study protocol was prepared 
according to Standard Protocol Items: Recommenda-
tions for Interventional Trials guidelines50 and regis-
tered with  clinicaltrials. gov on 6 March 2020 (https:// 
clinicaltrials. gov/ ct2/ show/ NCT04298450? term= ed+ to+ 
epi& draw= 2& rank= 1). REB- approved protocol amend-
ments will be posted on the site. The principal investiga-
tors and study team will meet regularly to review accrued 
data, data confidentiality, any adverse events, adherence 
to protocol design, recruitment and implementation. 
This intervention has been designed to have high likeli-
hood of adoption and readiness for spread and scale- up 
because it responds to a critical need, has a strong eviden-
tiary basis, has advantages over existing practice and is 
both low complexity and low cost.51 The study team is 
well- positioned to support widespread implementation 
of the intervention if successful. We have used an inte-
grated knowledge translation approach that leverages 
input from stakeholders, including patients, clinicians 
(both from the ED and EPI services), policymakers and 
relevant organisations throughout the study to champion 
the spread of the intervention to other EPI programmes 
and youth mental health services more broadly. This trial 
focuses on a particularly vulnerable population—young 
people transitioning from adolescence to adulthood and 
from the ED to EPI services—but the basic intervention 
is widely applicable. The software platform used to coor-
dinate this intervention is available at no charge, and the 
SMS functionality for sending and receiving messages 
carries a nominal fee, supporting broad uptake.
The results of the trial will be reported in scientific 
journal articles and shared with key stakeholders as they 
become available. Our study team includes the co- chair 
of the Early Psychosis Intervention Ontario Network, 
a network of over 50 EPI programmes across Ontario, 
and several members of the Canadian Consortium for 
Early Intervention in Psychosis, providing a durable and 
established community of practice for immediate spread. 
De- identified participant data will be available on reason-
able request other than system- level data held at ICES. 
Requests can be made by contacting the principal inves-
tigator Dr Nicole Kozloff at  nicole. kozloff@ camh. ca and 
will be managed by the Steering Committee.
This pragmatic randomised- controlled trial of a low- 
cost, low- complexity SMS intervention aims to improve the 
transition from the ED to EPI services for young people 
with psychosis. It targets a brief but critical period: if 
young people cannot even get in the door to EPI services, 
there is no way for them to reap the many known benefits 
of EPI care. Improving the ED to EPI transition has the 
potential to result in more young people with psychosis 
getting appropriate treatment earlier. The proposed 
intervention is also likely to be easily adaptable to other 
referral pathways to EPI services and youth mental health 
services more broadly. At potentially lower cost to the 
health system, applying this SMS intervention to the ED 
to EPI transition has the potential to lead to improved 
short- term symptoms and functioning, long- term disease 
trajectories, decreased burden on patients and families, 
and fewer deaths among young people with psychosis.
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ED to EPI: Using SMS (Text) Messaging to Improve the Transition from the 
Emergency Department to Early Psychosis Intervention for Young People 
with Psychosis  
Online Version - Informed Consent Form 
 
Principal Investigator: Dr. Nicole Kozloff 
Dr. George Foussias 
     Dr. Vicky Stergiopoulos 
     Dr. Aristotle Voineskos 
 
Co-Investigators:   Augustina Ampofo  Dr. Sean Kidd  
    Dr. Kelly Anderson  Dr. Paul Kurdyak  
    Sarah Bromley  Dr. Alexia Polillo 
    Jessica D’Arcey  Dr. Brittany Poynter 
    Dr. Jeff Daskalakis  Dr. Wei Wang 
    Dr. Claire de Oliveira Dr. Albert Wong 
    Lillian Duda   Dr. Juveria Zaheer  
    Dr. Joanna Henderson 
 
Sponsor:  Canadian Institutes of Health Research, CAMH Foundation 
 
Purpose of the Study: 
We invite you to participate in this study because you have been referred to the Slaight Centre for 
Early Intervention Services. The Slaight Centre is an outpatient program for young people 
experiencing a first episode of psychosis and their families. In this study we will examine if text 
messaging can improve the transition from the emergency department to early intervention services 
for youth. We hope that this study will eventually lead to young people getting appropriate treatment 
earlier and improve their long-term outcomes. Your participation in this study is voluntary. The 
following information is provided to help you make an informed decision whether or not to 
participate. 
 
What will I be asked to do as part of this study? 
If you decide to participate in this study, you will be asked to do the following: 
1) Intervention: You are being invited to take part in a study. If you consent to participate, you will 
be randomly assigned to receive one of two types of text messages. Random assignment means 
that you have an equal chance of being assigned to each text message group. If you are assigned 
to the text message intervention, you will receive text messages at a time of your choosing (e.g., 
morning, evening). You will be sent text messages with information about appointment details, 
education about psychosis, an opportunity to rate your distress, and appointment reminders. 
These text messages will continue until you attend your first consultation appointment, or for up 
to 30 days if you did not attend. If you are assigned to the other group, you will receive a one-
time text message. If you do not have a phone, one will be offered to you for the duration of the 
study with the expectation that it is returned at your first consultation appointment.  
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Please note that text messages are NOT being monitored constantly and if you are experiencing 
an urgent issue, this information should not be sent by text message. Instead, please visit your 
nearest emergency department. Additionally, this is not a direct line of communication with your 
care team and it is not a secure form of communication. You should not send any personal health 
information that is not requested by the text messages. 
 
2) Collection of data: We will also review your medical chart to obtain additional information 
about you. Information collected through this study will be transferred to the Institute for 
Clinical Evaluative Sciences (ICES). ICES is an organization that holds routinely collected data 
on health care use in Ontario. ICES is committed to protecting the privacy and security of 
health information. ICES is an approved unit under Ontario’s Personal Health Information 
Protection Act and follows the policies and procedures for privacy protection and data security 
approved by Ontario’s Information and Privacy Commissioner. Linking the data will involve 
using personal identifiers such as your name, date of birth, and OHIP number to identify your 
health service use. These identifiers will be removed as soon as the data is connected to ICES. 
The data will then be replaced by a scrambled code in order to decrease the likelihood of a data 
breach (when people get access to private information without permission) 
 
3) Follow up survey: You may be asked to complete a brief survey following your participation in 
the text message intervention. Your participation in the survey is voluntary. If you consent to 
study participation, you may receive a link to the online survey at the contact information of 
your choice (text message or email). The survey takes approximately 5 to 10 minutes to 
complete. If you complete the survey, you will be compensated with a $10 e-gift card sent to 
you by email or text message from your choice of a list of retailers. The survey contains 
questions about your experiences with the text message intervention. 
 
Are there risks involved? 
There are no known harms associated with participation in this study. If your text messaging plan does 
not include unlimited texting, you may incur additional charges on your cell phone bill. The study will 
not reimburse you for these charges. You may also feel emotional discomfort and fatigue from 
receiving recurrent text messages with appointment reminders and questions about how you are 
feeling. If you do feel this way, you may refuse to answer any question, or terminate your participation 
in this study at any point in time. You may be asked some questions during the survey that might make 
you feel somewhat uncomfortable. If you do feel uncomfortable, you may indicate this in the 
comments or skip the question. You can also pause the survey and continue at another time. Please be 
advised that if the researcher or study personnel sees that there is a risk to your safety or the safety of 
others, then steps will be taken to ensure your safety and the safety of others. Lastly, the security of 
information sent by email/text cannot be guaranteed.  
 
Are there benefits involved? 
No direct benefits to your health will likely result from this study. It is possible that the results of this 
study will increase engagement in early intervention services and may benefit other people now or 
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in the future. You will also receive compensation for your time and participation in the study. The 
investigators responsible for this study or CAMH are not conducting this study to receive commercial 
benefit. However, if this research produces financial returns from a commercialization of the results 
in the future, you will not receive any benefit from these returns. 
 
Can participation in this study end early? 
Participation in any research study is voluntary. Your decision whether or not to participate will not 
interfere with your right to healthcare or other services to which you are otherwise entitled. You can 
contact the research team through email or phone to withdraw from the study at any time.  After data 
is anonymized your responses cannot be withdrawn, however, no new data will be collected. 
Throughout your participation in this study, you will continue to receive usual care as agreed upon by 
you and your treatment team. In the event of research-related harm, you have not waived any legal 
rights/rights to legal recourse. 
 
Are study participants paid to participate in this study? 
Everyone who participates in the text messaging intervention will receive a $10 e-gift card by email 
or text message from your choice of a list of retailers. If you decide to withdraw before study end, you 
will still be paid for your time and participation. Those participants selected to participate in the follow 
up survey will receive another $10 e-gift card by email or text message from their choice of retailers 
for completing the survey.  
 
Will personal information about me be kept confidential? 
 The research data will be kept confidential from the inception of the study. 
 Any information about you obtained from this research will be kept as confidential (private) 
as possible unless disclosure is required by law. It is important to note that confidentiality 
will be protected to the extent permitted by law. However, there are 3 exceptions to our 
confidentiality policy. In any of the following situations, we are obligated by law to contact 
authorities: 1) if there is a serious possibility that you may harm yourself or others; 2) if you 
have been involved in any form of child abuse or neglect; 3) if you have been the victim of 
abuse by a healthcare worker 
 All data obtained from this research will be kept in a locked office and secured password 
database with limited access only to study personnel and authorized CAMH personnel. 
 To protect your identity and confidentiality, all personal identifiers (such as your name, birth 
date) will be removed (de-identified and replaced with a specific code number; the research 
records and data will be indicated by a case number rather than your name, and the 
information linking these case numbers with your identity will be kept separate from the 
research records. This information will be kept in a separate, secure location and will only 
be accessible to study personnel. 
 Study personnel may also access your health records for research purposes; your medical 
records will be kept confidential. 
 All electronic files will be stored on CAMH’s secure hospital or institutional network and 
will be password protected. 
 Other Canadian research centres (other than CAMH) may be involved in analyzing the data, 
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and if so this will be confidential, and your name will not be given out. 
 Following the completion of the study, the researchers intend to publish the results in 
scientific journals. You will not be identified in any of these reports. A report of the results  
of this project will be given to you if you request it. 
 The information you provide will not affect the usual care that you receive. 
 The investigators on this study will keep the data as long as necessary to fulfill the research 
purposes and in accordance with the applicable laws and regulations and will use enhanced 
security measures to store it.  
 De-identified data from this study may be shared with the research community at large to 
advance science and health. We will remove or code any personal information that could 
identify you before files are shared with other researchers to ensure that, by current  
scientific standards and known methods, no one will be able to identify you from the 
information we share. 
 Your de-identified research data (information about your diagnosis, symptoms, and study 
evaluations) may be shared with investigators at other Canadian research centres (other than 
CAMH). 
 
Will this research study involve the use or disclosure of my identifiable medical 
information? 
 Study personnel will retrieve information about your demographics and clinical care from your 
medical chart. This will be stored in a secure database with a case number rather than your 
personal identifiers. 
 
Who will have access to identifiable information related to my participation in this 
research study? 
Personal Health Information (PHI) is information about your physical or mental health or the health 
care that you receive that could identify you. In addition to the investigators listed on the first page of 
this consent form and their research staff, the following individual and/or programs will or may have 
access to identifiable information (which may include your identifiable medical information): 
a. Institute for Clinical Evaluative Sciences (ICES) is a prescribed entity under Ontario’s Personal 
Health Information Protection Act and adheres to policies and procedures for privacy protection 
and data security approved by Ontario’s Information and Privacy Commissioner.  
 
b. As part of the Research Services Quality Assurance Program, this study may be monitored and/or 
audited by a member of the Quality Assurance Team. Your research records and CAMH records 
may be reviewed during which confidentiality will be maintained as per CAMH policies and extent 
permitted by law.  
 
c. As a part of continuing review of the research, your study records may be assessed on behalf of 
the Research Ethics Board. A person from the research ethics team may contact you (if your 
contact information is available) to ask you questions about the research study and your consent 
to participate. The person assessing your file or contacting you must maintain their confidentiality 
to the extent permitted by law. 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-042751:e042751. 10 2020;BMJ Open, et al. Polillo A
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-042751:e042751. 10 2020;BMJ Open, et al. Polillo A
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-042751:e042751. 10 2020;BMJ Open, et al. Polillo A
Supplementary File 3 
 We will undertake a cost-effectiveness analysis, where the outcome of interest is 
consultation appointment attendance, adopting the perspective of the public third-party payer 
(i.e., the Ontario Ministry of Health). Using a costing algorithm developed in SAS and available 
at ICES,1 we will be able to estimate all direct patient-level healthcare costs incurred by the 
public third-party payer for both the intervention and control groups. In particular, we will include 
costs of hospitalizations, ED visits, physician services (i.e. primary care, psychiatry and other) 
and diagnostic tests, outpatient prescription drugs for individuals covered under the provincial 
public drug insurance plan, home care, long-term care, and other hospital-based care (which 
includes rehabilitation and complex continuing care). The costing methodology used in the 
algorithm includes a bottom-up/micro-costing approach to cost services at the individual level. 
This makes use of individual episodes of care or utilization in the healthcare system and their 
associated prices (or costs or amounts paid). A top-down approach, which allocates corporate 
aggregate (i.e. institutional) costs to individual visits or cases/episodes of care, will be applied in 
cases where individual unit costs are not available (e.g., for institutional care settings). In 
addition, we will include all costs associated with delivering both arms of the intervention. Costs 
will be reported in 2023 using the Consumer Price Index for Health and personal care (Statistics 
Canada). All costs and outcomes will be discounted at a rate of 1.5% per year, in line with the 
Canadian Agency for Drugs and Technologies in Health guidelines.2 The incremental cost-
effectiveness ratio (ICER) will be calculated as the difference in discounted mean costs between 
the intervention and control groups divided by the difference in attendance rates. We will use a 
net benefit regression approach to model probabilities of cost-effectiveness for each additional 
patient referred who attends their consultation appointment in the intervention compared with 
control group. In addition, we will undertake relevant sensitivity analyses to test the robustness 
of findings by varying relevant parameters, such as the discount rate. Finally, we will examine 
the real-world budget impact of implementing the intervention across Ontario, to estimate the 
cost to the Ministry of Health of implementing this model of care across the province and the 
potential cost-savings to the system associated with this. 
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